The funding will be used to move the ARGO-HT research platform into an FDA-cleared system to support the development of diagnostic tests.

The firm said that the unsecured $1.5 billion revolving credit facility through 2030 replaces another $1.5 billion credit facility through 2026.

Rounding out the other four largest financing rounds in 2024 are proteomics company Alamar Biosciences' $128 million Series C funding round, Karius' and Cytovale's $100 million raises, and early ...

Physicians Toxicology Laboratory had been accused of encouraging client healthcare practices to order drug tests for all patients regardless of medical need.